FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Maha Kosa

Research Profile

Living Beings

Concepts & Ideas

Physiology

Molecular Mimicry

Chemicals & Drugs

Procedures

Co-author Network

Publications

TOP 3
Peter S Dragovich; Thomas J Prins; Ru Zhou; Edward L Brown; Fausto C Maldonado; Shella A Fuhrman; Leora S Zalman; Tove tuntland; Caroline A Lee; Amy K Patick; David A Matthews; Thomas F Hendrickson; Maha B Kosa; Bo Liu; Minerva R Batugo; Jean-Paul R Gleeson; Sylvie K Sakata; Lijian Chen; Mark C Guzman; James W Meador; Rose Ann Ferre; Stephen T Worland
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 6. Structure-activity studies of orally bioavailable, 2-pyridone-containing peptidomimetics.
Peter S Dragovich; Thomas J Prins; Ru Zhou; Stephen E Webber; Joseph T Marakovits; Shella A Fuhrman; Amy K Patick; David A Matthews; Caroline A Lee; CE Ford; B J Burke; Paul Rejto; Thomas F Hendrickson; Tove tuntland; Edward L Brown; James W Meador; Rose Ann Ferre; JE Harr; Maha B Kosa; Stephen T Worland
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements.
Stephen W Kaldor; V J Kalish; J F Davies; Bhasker Shetty; JE Fritz; K Appelt; J A Burgess; K M Campanale; Nikolay Y Chirgadze; David Clawson; B A Dressman; S D Hatch; D A Khalil; Maha B Kosa; P P Lubbehusen; M A Muesing; Amy K Patick; Siegfried H Reich; K S Su; J H Tatlock
Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Maha Kosa (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2002: Peter S Dragovich; Thomas J Prins; Ru Zhou; Edward L Brown; Fausto C Maldonado; Shella A Fuhrman; Leora S Zalman; Tove tuntland; Caroline A Lee; Amy K Patick; David A Matthews; Thomas F Hendrickson; Maha B Kosa; Bo Liu; Minerva R Batugo; Jean-Paul R Gleeson; Sylvie K Sakata; Lijian Chen; Mark C Guzman; James W Meador; Rose Ann Ferre; Stephen T Worland
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 6. Structure-activity studies of orally bioavailable, 2-pyridone-containing peptidomimetics.
Journal of medicinal chemistry 2002;45(8):1607-23.
1999: Peter S Dragovich; Thomas J Prins; Ru Zhou; Stephen E Webber; Joseph T Marakovits; Shella A Fuhrman; Amy K Patick; David A Matthews; Caroline A Lee; CE Ford; B J Burke; Paul Rejto; Thomas F Hendrickson; Tove tuntland; Edward L Brown; James W Meador; Rose Ann Ferre; JE Harr; Maha B Kosa; Stephen T Worland
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements.
Journal of medicinal chemistry 1999;42(7):1213-24.
1997: Stephen W Kaldor; V J Kalish; J F Davies; Bhasker Shetty; JE Fritz; K Appelt; J A Burgess; K M Campanale; Nikolay Y Chirgadze; David Clawson; B A Dressman; S D Hatch; D A Khalil; Maha B Kosa; P P Lubbehusen; M A Muesing; Amy K Patick; Siegfried H Reich; K S Su; J H Tatlock
Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease.
Journal of medicinal chemistry 1997;40(24):3979-85.